Sabra Healthcare REIT, Inc.
SBRAReal Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +22.2%
- Free cash flow
- n/m
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.
Follow SBRA
Alert me
Sabra Healthcare REIT, Inc. (SBRA) EV/Sales
As of Nov 20, 2026, Sabra Healthcare REIT, Inc. (SBRA) trades at a EV/Sales of 8.3×. Over the past ten years it has ranged from 5.2× (March 2020) to 18.0× (October 2017); the current reading is higher than 7% of that period. That is above the Reit Healthcare Facilities industry median of 7.8× and above the Real Estate sector median of 7.3×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 9.1× | (0.34%) |
| FY2024 | 9.1× | 4.26% |
| FY2023 | 8.7× | 1.58% |
| FY2022 | 8.6× | (6.75%) |
| FY2021 | 9.2× | (6.40%) |
| FY2020 | 9.8× | 2.57% |
| FY2019 | 9.6× | (2.15%) |
| FY2018 | 9.8× | (17.03%) |
| FY2017 | 11.8× | 10.58% |
| FY2016 | 10.7× | (2.66%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 8.1× | (4.89%) |
| Jun 2026 | 8.5× | (6.47%) |
| Mar 2026 | 9.1× | 0.31% |
| Dec 2025 | 9.1× | (1.49%) |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| DHC Diversified Healthcare Trust compare | 2.7× |
| AHR American Healthcare REIT, Inc. compare | 5.1× |
| HR Healthcare Realty Trust Incorporated compare | 5.9× |
| DOC Healthpeak Properties, Inc. compare | 7.2× |
| LTC LTC Properties, Inc. compare | 7.8× |
| NHI National Health Investors, Inc. compare | 8.3× |
| SBRA Sabra Healthcare REIT, Inc. | 8.3× |
| OHI Omega Healthcare Investors, Inc. compare | 13.5× |
| CTRE CareTrust REIT, Inc. compare | 17.0× |
| Reit Healthcare Facilities industry median | 7.8× |
| Real Estate sector median | 7.3× |
| Market median | 1.9× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on SBRA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement